AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on August 17, 2026

Kate Stallings Selected to Speak at 2027 NAHB International Builders' Show
America’s Krewe Heads West: Krewe of Europa to Bring International Spirit to Ocean Beach Holiday Parade
SurnaCare Launches AI-Powered Postpartum Companion Built Entirely Around the Mother
SRS Team Celebrates Milestone of 1,111 Homes Sold Since Launching in 2017
Lydonia Expands AI Capabilities with Launch of Enabuild AI Division & Acquisition of International Cognitive Initiative
Michele Marie Campbell, Recognized By Influential Women, Reflects Nearly Two Decades Of Service In Nursing And Policing
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 27, 2026 in Chicago
Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
Global AI Adoption Accelerates as Investment Surges Past $194 Billion, Reshaping Enterprise and National Competitive Strategy
Floating Point Announces $125 Million Fund III to Embrace Complexity
The Belstead Welcomes Residents in August as North Attleboro Gains 304 New Apartments
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MKS Inc. Earns 2026 Zhen Ding Technology Group Distinguished Contribution Awards for Service Excellence and Technology Innovation
Outbound Sales Pro Names Kyle Weiss Chief Revenue Officer
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.